Pfizer to Buy Array BioPharma in Deal Worth $11.4 Billion

June 17, 2019 josborne

News
Pfizer is delving deeper into cancer research with a roughly $11.4 billion deal for Array BioPharma, a drug developer that has seen its shares soar since announcing positive clinical trial results earlier this spring.
Contributed Author: 
The Associated Press
Topics: 

Read more...

Previous Article
Ruiz Foods Products Inc. Recalls Bacon Breakfast Wrap Products
Ruiz Foods Products Inc. Recalls Bacon Breakfast Wrap Products

NewsRuiz Foods Products Inc. is recalling 246,514 pounds of frozen, not-ready-to-eat breakfast wrap product...

Next Article
Pfizer to Buy Array BioPharma in Deal Worth $11.4 Billion
Pfizer to Buy Array BioPharma in Deal Worth $11.4 Billion

Pfizer is delving deeper into cancer research with a roughly $11.4 billion deal for Array BioPharma, a drug...

×

Type in your corporate email address to subscribe to our latest hub updates

Last Name
First Name
Thank you!
Error - something went wrong!